Literature DB >> 1954917

Endocrine- and autocrine-mediated regulation of rat ovarian (theca-interstitial) interleukin-1 beta gene expression: gonadotropin-dependent preovulatory acquisition.

A Hurwitz1, E Ricciarelli, L Botero, R M Rohan, E R Hernandez, E Y Adashi.   

Abstract

We, and others have recently demonstrated the ovary to be a site of interleukin-1 (IL-1) reception and action. Since IL-1 is an established mediator of inflammation and since ovulation may constitute an inflammatory-like reaction, consideration was given to the possibility that IL-1 may play an intermediary role in the ovulatory process. To begin to evaluate the above hypothesis, we have set out to evaluate rat ovarian IL-1 beta gene expression, to determine its cellular localization, and to study its modulation by key endocrine and autocrine regulatory signals. To this end, use was made of a solution hybridization/RNase protection assay in which rat ovarian total RNA (20 micrograms) was hybridized with a [32P]-labeled 272 base rat IL-1 beta antisense riboprobe. To assess rat ovarian IL-1 beta gene expression under in vivo circumstances, use was made of an established experimental model capable of simulating naturally-occurring follicular maturation, ovulation, and corpus luteum formation. Specifically, a single subcutaneous injection of PMSG (15IU/rat) was followed (48h) later by an ovulatory dose (15IU) of human chorionic gonadotropin (hCG). A faint protected fragment 222 bases long corresponding to the IL-1 beta message was detectable in whole ovarian material prior to gonadotropic stimulation. Treatment with PMSG for 48h resulted in a modest, albeit measurable increase in the densitometrically-quantified steady state levels of the ovarian IL-1 beta message. Most striking, however, were the increments noted in the relative abundance of ovarian IL-1 beta transcripts following a 6h exposure to hCG producing a 4 to 5-fold increase (P less than 0.05) over the untreated state at a time point approximately 6h prior to projected follicular rupture. Subsequent evaluation of ovarian IL-1 beta transcripts, 24 and 48h following hCG administration, revealed significant (P less than 0.05) decrements (relative to the 6h peak) to a level comparable to that seen at the conclusion of 48h of treatment with PMSG. Cellular localization studies revealed the gonadotropin-dependent IL-1 beta mRNA to be theca-interstitial cell-exclusive. To assess rat ovarian IL-1 beta gene expression under in vitro circumstances, we have set out to determine whether IL-1 itself may influence the relative level of its own message. Treatment of whole ovarian dispersates with rhIL-1 beta (10ng/ml) for 4 and 24h resulted in a marked (P less than 0.05) time-dependent increase (up to 12-fold) in the relative abundance of IL-1 beta transcripts when compared with untreated controls.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954917     DOI: 10.1210/endo-129-6-3427

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

Review 1.  Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?

Authors:  Milica Popovic; Gideon Sartorius; Mirjam Christ-Crain
Journal:  Semin Immunopathol       Date:  2019-05-28       Impact factor: 9.623

Review 2.  Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications.

Authors:  M G Da Broi; V S I Giorgi; F Wang; D L Keefe; D Albertini; P A Navarro
Journal:  J Assist Reprod Genet       Date:  2018-03-02       Impact factor: 3.412

3.  The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. Possible role for interleukin-1, a putative intermediary in the ovulatory process.

Authors:  S Kol; I Ben-Shlomo; K Ruutiainen; M Ando; T M Davies-Hill; R M Rohan; I A Simpson; E Y Adashi
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

4.  Rat ovarian interleukin-1alpha: interleukin-1-dependent in vitro expression.

Authors:  S Kol; K H Wong; M Ando; I Ben-Shlomo; E Y Adashi
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

5.  Neuroendocrineimmunology (NEI) at the turn of the century: towards a molecular understanding of basic mechanisms and implications for reproductive physiopathology.

Authors:  B Marchetti; M C Morale; F Gallo; N Batticane; Z Farinella; M Cioni
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

6.  Interleukin-1β inhibits luteinizing hormone-induced plasminogen activator activity in rat preovulatory folliclesin vitro.

Authors:  N P Bonello; R J Norman; M Brännström
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

Review 7.  Cytokines and reproduction.

Authors:  C Simón; M L Polan
Journal:  West J Med       Date:  1994-05

8.  The morphogenic/cytotoxic and prostaglandin-stimulating activities of interleukin-1 beta in the rat ovary are nitric oxide independent.

Authors:  I Ben-Shlomo; E Y Adashi; D W Payne
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

9.  Interleukin-1 (IL-1) system gene expression in granulosa cells: kinetics during terminal preovulatory follicle maturation in the mare.

Authors:  Alain Martoriati; Nadine Gérard
Journal:  Reprod Biol Endocrinol       Date:  2003-05-16       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.